Press release
SHL announces invitation to an Annual General Meeting
Tel Aviv / Zurich / New York, April 22, 2025 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN; NASDAQ: SHLT) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, today announced that an Annual General Meeting of the Shareholders (the "AGM") will be held on May 28, 2025 at 1:00 p.m. (Israel Time), at the Company's registered office, located at 90 Yigal Alon Street, Ashdar Building, Tel Aviv, Israel.
The agenda shall include the following matters:
- Presentation and discussion of the Company's financial statements for the fiscal year ending December 31, 2024;
- To approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company's independent registered public accounting firm until the next annual meeting of shareholders, and to authorize the Board, upon recommendation of the audit committee, to fix the remuneration of said independent registered public accounting firm;
- To re-elect the four current directors of the Company (excluding our two external directors, whose terms of office are not expiring at the AGM and who are not up for reelection at the AGM), who shall serve as directors of the Company until the next annual general meeting of the shareholders of the Company, as follows: (1) Prof. Amir Lerman, (2) Mr. Ido Nouberger, (3) Dr. Itamar Offer, and (4) Mr. Nir Rotenberg;
- To approve the payment of fees for consulting services to be provided to the Company by Dr. Itamar Offer (not in connection with his office as the Chairman of the Board); and
- To approve the payment of an annual cash bonus to Lior Haalman, the Company's Chief Financial Officer.
The above is more fully set forth in the Notice and Proxy Statement for the AGM available on the Company's website.
The record date of the AGM is April 30, 2025.
One or more shareholders holding shares representing at least one percent (1%) of the voting rights at the AGM may request the Board, in writing, not later than seven (7) days from the date of the Notice of the AGM, to include an item on the agenda of the AGM, provided that shareholders who wish to nominate a director candidate for the AGM must severally or jointly
1/2
hold at least 5% of the voting rights at the AGM. Such item shall be included on the AGM's agenda, provided that the Board found it to be suitable for discussion at the AGM. Should there be any changes in the agenda of the AGM, an amended Notice, Proxy Statement and form of Written Ballot shall be available on the Company's website at https://www.shl-telemedicine.com/general-meeting/not later than fourteen (14) days from the date of the Notice of the AGM.
Each of the Notice and the Proxy Statement for the AGM shall not be published in newspapers, and can be downloaded on https://www.shl-telemedicine.com/general-meeting/or on the website of the U.S. Securities and Exchange Commission at www.sec.gov.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200). For more information, please visit our website at www.shl-telemedicine.com.
For further information please contact:
Fabienne Farner, IRF, Phone : +41 43 244 81 42, farner@irf-reputation.ch
2/2